Kardiyak Sendrom X’li Hastalarda Epikardiyal Yağ Dokusu Kalınlığının ve Serum Omentin Seviyelerinin Değerlendirilmesi

Abstract

Giriş: Bu çalışmanın amacı kardiyak sendrom X’li hastalarda epikardiyal yağ dokusu ile serum omentin seviyeleri arasındanki ilişkiyi değerlendirmektir. Hastalar ve Yöntem: Kliniğimizde tanısı konan 51 kardiyak sendrom X hastası, hasta grubuna ve 46 sağlıklı olgu ise kontrol grubuna dahil edilmiştir. Demografik veriler, rutin labarotuvar testleri hsCRP seviyeleri çalışıldı. Epikardiyal yağ dokusu kalınlığı transtorasik ekokardiyografi ile serum omentin seviyeleri ise ELISA yontemi ile ölçüldü. Bulgular: Epikardiyal yağ dokusu kalınlığı hasta grubunda anlamlı olarak daha kalındı (p< 0.001). Kontrol grubu ile karşılaştırıldığında, serum omentin seviyeleri hasta grubunda anlamlı olarak daha düşüktü (p< 0.001). Kardiyak sendrom X’li hastalarda medyan yaş anlamlı olarak daha yüksekti (p< 0.001). Lökosit sayımı ve hsCRP seviyleri iki grup arasından anlamlı farklılık göstermedi (sırasıyla; p= 0.46, p= 0.49 ) Sonuç: Güncel literatüre benzer şekilde, yapmış olduğumuz çalışmamızda, kardiyak sendrom X’li hastalarda epikardiyal yağ dokusu kalınlığının artmış ve serum omentin seviyelerinin düşük olduğunu gösterdik. Bu bulgular ışığında artmış epikardiyal yağ dokusu, serum omentin seviyelerindeki düşüşe neden olarak koroner sendrom X hastalığının patolojisinde rol oynayabilir.

Keywords

• Epikardiyal yağ dokusu,omentin,kardiyak sendrom X

Evaluation of the Epicardial Fat Tissue Thickness and Serum Omentin Levels in Patients with Cardiac Syndrome X

Abstract

Introduction: The aim of this study was to evaluate the correlation between the epicardial fat tissue thickness (EFTT) and serum omentin levels in patients with cardiac syndrome X (CSX). Patients and Methods: A total of 51 patients with CSX admitted to our clinic were included in the patient group, and 46 healthy subjects were included in the control group. Demographics, routine laboratory tests, and high sensitive C-reactive protein (hsCRP) levels of all patients were recorded. The EFTT was measured with transthoracic echocardiography (TTE). Serum omentin levels were measured with the enzyme-linked immunosorbent assay. Results: The EFTT was significantly higher in the CSX group (p< 0.001). Serum omentin levels were significantly lower in patients with CSX in comparison with the control group (p< 0.001). The median age was significantly higher in the CSX group (p< 0.001). The white blood count and hsCRP levels showed no significant difference between the CSX and the control group (p= 0.46 and p= 0.49, respectively). Conclusion: In our study, we found increased epicardial fat tissue (EFT) thickness and decreased serum omentin levels in patients with CSX, a finding similar with the literature. Thus, increased EFT thickness may play a role in the pathophysiology of CSX by causing a decrease in the serum omentin level.

Keywords

• Epicardial fat tissue,omentin,cardiac syndrome X

References

1. 1. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-53.
2. 2. Vázquez-Rey E, Kaski JC. Cardiovascular syndrome X and endothelial dysfunction. Rev Esp Cardiol 2003;56:181-92.
3. 3. Huang PH, Chen YH, Chen YL, Wu TC, Chen JW, Lin SJ. Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 2007;93:1064-70.
4. 4. Parsaei MS, Nabati M, Yazdani J, Bagheri B, Ghaemian A, Saffar N. Relationship between epicardial fat and coronary microvascular dysfunction. Kardiologia Polska 2014;72:417-24.
5. 5. Bugiardini R, Manfrini O, De Ferrari GM. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med 2006;166:1391-5.
6. 6. Gedikli O, Ozturk M, Turan OE, Ilter A, Hosoglu Y, Kiris G. Epicardial adipose tissue thickness is increased in patients with cardiac syndrome X. Int J Clin Exp Med 2014;7:194-8.
7. 7. Iacobellis G, di Gioia CR, Cotesta D, Petramala L, Travaglini C, De Santis V, et al. Epicardial adipose tissue adiponectin expression is related to intra coronary adiponectin levels. Horm Metab Res 2009;41:227-31.
8. 8. Iacobellis G, Bianco AC. Epicardial adipose tissue: emerging physiological, pathophysiological and clinica features. Trends Endocrinol Metab 2011;22:450-7.

9. 9. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is asource of inflammatory mediators. Circulation 2003;108:2460-6.
10. 10. Lau DCW, Dhillon B, Yan HY, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005;288:2031-41.
11. 11. Mattu HS, Randeva HS. Role of adipokines in cardio vascular disease. J Endocrinol 2013;216:17-36.
12. 12. De Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007;56:1655-61.
13. 13. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O’Hare P, Lehnert H, et al. Omentin-1, a novel adipokine, is decreased in over weight insulin-resistant women with polycystic ovary syndrome: exvivoand in vivoregulation of omentin-1 by insulin and glucose. Diabetes 2008;57:801-8.
14. 14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-72.
15. 15. National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation 2002;106:3143-421.
16. 16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American society of echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
17. 17. Sen N, Tavil Y, Erdamar H, Yazici HU, Cakir E, Akgül EO, et al. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. Anatol J Cardiol 2009;9:371-9.
18. 18. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impair edendothelium - dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659-64.
19. 19. Quyyumi AA, Cannon RO, Panza JA, Diodati JG, Epstein SE. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 1992;86:1864-71.
20. 20. Marinescu MA, Löffler AI, Ouellette M, Smith L, Kramer CM, Bourque JM. Coronary microvascular dysfunction and microvascular angina: A systematic review of therapies. JACC Cardiovasc Imaging 2015;8:210-20.
21. 21. Chen C, Wei J, AlBadri A, Zarrini P, Bairey Merz CN. Coronary microvascular dysfunction. Epidemiology, pathogenesis, prognosis, diagnosis, risk factors and therapy. Circ J 2016;81:3-11.
22. 22. Murthy VL, Naya M, Taqueti VR, Foster CR, Gaber M, Hainer J, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 2014;129:2518-27.
23. 23. Eroğlu S. How do we measure epicardial adipose tissue thickness by transthoracic echocardiography? Anatol J Cardiol 2015;15:416-9.
24. 24. Şengül C, Özveren O. Epicardial adipose tissue: a review of physiology, pathophysiology, and clinical applications. Anatol J Cardiol 2013;13:261-5.
25. 25. Sade LE, Eroglu S, Bozbaş H, Ozbiçer S, Hayran M, Haberal A, et al. Relation between epicardial fat thickness and coronary flow reserve in wome with chest pain and angiographically normal coronary arteries. Atherosclerosis 2009;204:580-5.
26. 26. Gaborit B, Kober F, Jacquier A, Moro PJ, Flavian A, Quilici J, et al. Epicardial fat volume is associated with coronary microvascular response in healthy subjects: A pilot study. Obesity 2012;20:1200-5.
27. 27. Moreno-Navarrete JM, Ortega F, Castro A, Sabater M, Ricart W, Fernández-Real JM. Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity 2011;19:1552-9.
28. 28. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011;408:339-43.
29. 29. Zhong X, Zhang HY, Tan H, Zhou Y, Liu FL, Chen FQ, et al. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 2011;32:873-8.